Table 5.

Association between NLR and clinical benefit in BRAFi group.

	Clinical benefit at 12 weeks
NLR timepoint	NLR < 5	NLR ≥ 5	p
Baseline (n = 65)	76%	65%	0.413
Week 3 (n = 59)	69%	70%	0.999
Week 6 (n = 53)	74%	55%	0.155
Week 9 (n = 54)	76%	60%	0.230